Related Experiment Video
Updated: Aug 26, 2025

09:03
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
4.9K
Development of an Algorithm for Cervical High-Grade Squamous Intraepithelial Lesion Based on Breath Print Analysis
Laura A Dokter1, Jeanine H À Nijeholt1, Bernadette M Rigterink1
1Department of Obstetrics and Gynecology, Isala Hospital, Zwolle, the Netherlands.
Journal of Lower Genital Tract Disease
|October 5, 2022
Summary
An electronic nose (e-nose) can detect volatile organic compounds to identify high-grade squamous intraepithelial lesions (HSIL) of the cervix. This diagnostic algorithm shows high sensitivity and specificity, warranting further validation for clinical use.
Area of Science:
- Gynecologic Oncology
- Biomarker Discovery
- Medical Diagnostics
Background:
- Cervical high-grade squamous intraepithelial lesions (HSIL) require accurate and timely diagnosis.
- Current diagnostic methods may have limitations, necessitating novel approaches.
- Volatile organic compounds (VOCs) in breath may serve as potential biomarkers for cervical cancer precursors.
Purpose of the Study:
- To develop and evaluate an algorithm for diagnosing cervical HSIL using an electronic nose (e-nose).
- To assess the diagnostic performance of the e-nose based on VOC patterns.
Main Methods:
- A pilot study involving 25 patients with confirmed HSIL and 26 controls.
- Breath samples were analyzed using an e-nose to detect VOC patterns.
- Machine learning techniques were employed to build a predictive model for HSIL detection.
Main Results:
- The developed algorithm demonstrated a sensitivity of 0.88 and specificity of 0.92 for HSIL detection.
- Positive and negative predictive values were 0.92 and 0.89, respectively.
- A Cohen κ coefficient of 0.80 indicated substantial agreement.
Conclusions:
- The e-nose effectively distinguishes VOC patterns between HSIL patients and controls.
- The algorithm shows promise for non-invasive HSIL diagnosis.
- Further validation studies are required prior to clinical implementation.

